Carlson Capital L P Laboratory Corp Of America Holdings Transaction History

Carlson Capital L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$159.77 - $178.1 $9.4 Million - $10.5 Million	-58,840 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$144.16 - $172.9 $7.44 Million - $8.92 Million	-51,603 Reduced 46.72%	58,840 $10.2 Million
Q1 2019 May 14, 2019	BUY	$123.7 - $156.3 $4.07 Million - $5.14 Million	32,893 Added 42.42%	110,443 $16.9 Million
Q4 2018 Feb 13, 2019	BUY	$120.82 - $174.09 $6.56 Million - $9.45 Million	54,300 Added 233.55%	77,550 $9.8 Million
Q3 2018 Nov 14, 2018	BUY	$167.67 - $188.27 $3.9 Million - $4.38 Million	23,250 New	23,250 $4.04 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital L P with notifications on news.